Interchangeable Biologics Clarity Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 25, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709-2710)
May 25, 2022
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Interchangeable Biologics Clarity Act
This bill provides a statutory definition for first interchangeable biosimilar biological product and makes other technical changes with respect to the provisions that establish the corresponding periods of market exclusivity.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709-2710)
Related & companion bills
1
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
2
Cite this page
U.S. Congress. (2026). S. 4303: Interchangeable Biologics Clarity Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-4303/
"S. 4303: Interchangeable Biologics Clarity Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-4303/.
S. 4303, 117th Cong. (2026), https://openamerica.io/bill/117-S-4303/.
[S. 4303: Interchangeable Biologics Clarity Act](https://openamerica.io/bill/117-S-4303/)